U.S. Markets closed

Teva Pharmaceutical Industries Limited (TEVA)


NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
29.420-0.46 (-1.54%)
At close: 4:00PM EDT
People also watch
MYLGILDNVSAMGNABT
Interactive chart
Previous Close29.880
Open29.920
Bid0.000 x
Ask0.000 x
Day's Range29.360 - 30.050
52 Week Range29.360 - 56.440
Volume5,938,099
Avg. Volume6,656,795
Market Cap30.02B
Beta0.56
PE Ratio (TTM)377.18
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.36 (4.55%)
Ex-Dividend Date2017-02-28
1y Target EstN/A
Trade prices are not sourced from all markets
  • Benzinga4 hours ago

    It's Easy To Be Skeptical Of Mylan, But Don't Ignore This Pending PDUFA Date

    Commenting on Mylan N.V. (NASDAQ: MYL ), Barclays said there's understandably reason to be skeptical that the company will win approval for its generic version of Copaxone now after years of promises. ...

  • 3 Drug Stocks Billionaire Money Managers Dumped Big-Time in the First Quarter
    Motley Fool8 hours ago

    3 Drug Stocks Billionaire Money Managers Dumped Big-Time in the First Quarter

    Billionaires appear to have focused on drug stocks that were mired in debt in Q1.

  • Barrons.com3 days ago

    Valeant Pharmaceuticals: Intrigued…Really?

    This very blog has offered up no shortage of opinions on shares Valeant Pharmaceuticals International (VRX)...some good, some bad and some still undecided. Quoting from Gilbert’s recent note, StreetInsider reported: We have been cautious/skeptical on VRX for a very long time, and uncertainties around the growth potential and durability of key franchises, the potential cost of past sins, and the heavy debt load have kept us at Hold.